Clinical Trials List
2024-01-16 - 2026-06-30
Phase III
Recruiting7
ICD-10E11.65
Type 2 diabetes mellitus with hyperglycemia
ICD-10E11.8
Type 2 diabetes mellitus with unspecified complications
ICD-9250.92
Diabetes with unspecified complication, Type II [non-insulin dependent type][NIDDM type][adult-onset type] or unspecified type, uncontrolled
-
Trial Applicant
NOVO NORDISK PHARMA (TAIWAN) LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Harn-Shen Chen Division of Endocrinology
- 吳崇暉 Division of Endocrinology
- 陳涵栩 Division of Endocrinology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 白哲聲 Division of Endocrinology
- 歐昱侖 Division of Endocrinology
- Tsung-Hsien Lin Division of Cardiovascular Diseases
- 盧子文 Division of Endocrinology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
50 participants
-
Global
1000 participants
